RITA JEYARANI SHKULLAKU
Allopathic & Osteopathic Physicians|Internal Medicine ANNAPOLIS, MD NPI 1699900522
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine MD Novo Nordisk AS All categories
General Payments — all program years on this page
$2,193.19
- Category: General Payments
- Program years: PY2018–2024
- Record count: 102
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,027.06 across 41 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,027.06 | 41 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $235.21 | 9 |
| JAZZ PHARMACEUTICALS INC. | $142.04 | 1 |
| ABBVIE INC. | $90.36 | 4 |
| Exact Sciences Corporation | $89.51 | 3 |
| Astellas Pharma US Inc | $65.59 | 3 |
| Hologic Sales and Service, LLC | $46.26 | 2 |
| Sumitomo Pharma America, Inc. | $34.22 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $30.24 | 2 |
| ABIOMED | $29.82 | 1 |
| Abbott Laboratories | $29.13 | 2 |
| Merck Sharp & Dohme Corporation | $22.60 | 1 |
| ATRICURE, INC. | $22.22 | 1 |
| Vertical Pharmaceuticals, LLC | $22.16 | 1 |
| Janssen Pharmaceuticals, Inc | $21.16 | 1 |
| GlaxoSmithKline, LLC. | $18.84 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.72 | 1 |
| PFIZER INC. | $18.69 | 1 |
| Seqirus USA Inc | $18.68 | 1 |
| DEXCOM, INC. | $18.38 | 1 |
| ResMed Corp | $18.13 | 1 |
| Lundbeck LLC | $17.71 | 1 |
| Lilly USA, LLC | $17.39 | 1 |
By program year
Records — PY2024 (41)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.